IP Library Granted Patent US 9,220,596
Granted Patent B2
US 9,220,596 · App. 14/047,677 · Granted Dec 29, 2015

Bone graft materials and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,220,596
App. No.
14/047,677
Granted
Dec 29, 2015
Kind
B2
Abstract

Compositions, materials, methods and kits for bone grafting are described. In some embodiments, a bone graft composition includes about 15% to about 20% by weight collagen, about 55% to about 70% by weight bioactive glass, and about 15% to about 30% by weight a calcium phosphate. The bioactive glass and the calcium phosphate together are about 80% to about 85% by weight of the bone graft composition. In some embodiments, a bone graft composition includes a collagen matrix and a plurality of bioactive glass particulates dispersed throughout the collagen matrix. The collagen matrix is about 20% to about 60% by weight of the bone graft composition, and the bioactive glass is about 40% to about 80% of the bone graft composition. In some embodiments, a majority of the bioactive glass particulates are about 53 μm to about 425 μm in size.

Claims (20)

1. A bone graft composition comprising:

about 15% to about 20% by weight collagen;

about 55% to about 70% by weight bioactive glass, the bioactive glass having a size within a range of about 53 μm to about 425 μm in size, at least 85% of the bioactive glass having a size within a range of 212 μm to 425 μm in size; and

about 15% to about 30% by weight calcium phosphate.

2. The bone graft composition of claim 1 , wherein the bioactive glass and the calcium phosphate together are about 80% to about 85% by weight of the bone graft composition.

3. The bone graft composition of claim 1 , wherein the collagen is type I collagen.

4. The bone graft composition of claim 1 , wherein the bioactive glass includes particles having a smooth surface.

5. The bone graft composition of claim 1 , wherein the calcium phosphate comprises about 40% to about 80% tricalcium phosphate and about 20% to about 60% hydroxyapatite.

6. The bone graft composition of claim 5 , further comprising about 15% by weight type I collagen, about 55% to about 65% by weight bioactive glass, and about 20% to about 30% by weight calcium phosphate.

7. The bone graft composition of claim 6 , wherein a weight ratio of the collagen to the bioactive glass to the calcium phosphate is about 15%:55%:30%, respectively.

8. The bone graft composition of claim 6 , wherein a weight ratio of the collagen to the bioactive glass to the calcium phosphate is about 15%:60%:25%, respectively.

9. The bone graft composition of claim 6 , wherein a weight ratio of the collagen to the bioactive glass to the calcium phosphate is about 15%:65%:20%, respectively.

10. The bone graft composition of claim 1 , wherein the bioactive glass is 45S5 glass.

11. A bone graft composition consisting of: a collagen and a bioactive glass dispersed throughout the collagen, the bioactive glass having a size within a range of about 53 μm to about 425 μm, at least 85% of the bioactive glass having a size within a range of 212 μm to 425 μm; the collagen and the bioactive glass collectively comprising 100% by weight of the bone graft composition, the collagen being about 20% to about 60% by weight of the bone graft composition and the bioactive glass is about 40% to about 80% by weight of the bone graft composition.

12. The bone graft composition of claim 11 , wherein the collagen is in the form of a porous matrix.

13. The bone graft composition of claim 11 , wherein the bioactive glass has a smooth surface.

14. The bone graft composition of claim 11 , wherein the bioactive glass is about 80% by weight of the bone graft composition.

15. The bone graft composition of claim 11 , wherein the bioactive glass is about 60% by weight of the bone graft composition.

16. The bone graft composition of claim 11 , wherein the bioactive glass is 45S5 glass.

17. The bone graft composition of claim 11 , wherein the collagen includes type I collagen.

Assignments (7)
SECURITY INTEREST Recorded Aug 1, 2025
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 071904/0465 →
RELEASE OF SECURITY INTEREST Recorded Aug 1, 2025
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: BIOVENTUS LLC
Reel/Frame 071909/0861 →
RELEASE OF SECURITY INTEREST PREVIOUSLY RECORDED AT REEL/FRAME (040823/0983) Recorded Dec 17, 2019
From: JPMORGAN CHASE BANK, N.A,, AS COLLATERAL AGENT
To: BIOVENTUS LLC
Reel/Frame 051336/0511 →
SECURITY INTEREST Recorded Dec 13, 2019
From: BIOVENTUS LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 051272/0143 →
PATENT SECURITY AGREEMENT Recorded Dec 6, 2016
From: BIOVENTUS LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 040823/0983 →
MERGER AND CHANGE OF NAME Recorded Nov 14, 2016
From: BIOSTRUCTURES, LLC; BIOVENTUS, LLC
To: BIOVENTUS, LLC
Reel/Frame 040311/0240 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2013
From: COOK, RUSSELL L.; ANTONE, DURAID S.
To: BIOSTRUCTURES, LLC
Reel/Frame 031357/0636 →